outcomes from the resonate 2 and helios trials—clinical impact
Published 8 years ago • 64 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
7:37
resonate, resonate-2 and helios: three major clinical trials in cll research
-
2:15
clinical impact of the resonate-2 trial in cll
-
3:08
resonate-2 trial: safety and efficacy updates
-
3:06
upfront ibrutinib: resonate-2 trial
-
1:56
resonate-2 trial of ibtrutinib in cll
-
2:00
does the helios trial indicate a paradigm shift in the management of cll?
-
9:16
adverse events from btki's in clinical trials for b-cell malignancies - dr. brian koffman ash 2022
-
35:31
cll: btk inhibitors in hematologic oncology pathways - pathway-guided choices
-
7:45
early trial of sonrotoclax to treat chronic lymphocytic leukemia (cll) - ash 2023 dr. mazyar shadman
-
10:39
clinical outcomes of venetoclax treatment in cll patients - dr. paul hampel ash 2023
-
48:36
what are the current cll clinical trials? with ryan jacobs, md
-
3:28
resonate-2 follow up: ibrutinib and chlorambucil 5 years on
-
1:12
dr. brown on lessons learned from resonate-2 trial for cll
-
14:31
side effects w/ acalabrutinib vs ibrutinib for chronic lymphocytic leukemia (cll) - dr. john seymour
-
4:45
segment 4- impact of major trials on cll treatment
-
6:45
the changing treatment paradigm in cll
-
1:08
re-analysis of resonate-2 trial of ibrutinib vs chlorambucil in cll
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
1:28
overview of resonate-2 clinical trial of ibrutinib in cll
-
1:55
paul m. barr, md, elaborates on outcomes from the resonate trial in relapsed/refractory cll
-
15:19
understanding clinical trials
-
42:54
the clinical importance of cardiology related secondary findings